Tune in to Cleveland Clinic MD Cleveland Clinic Florida #IBDPrimeTime on 3/12/24, to hear Benjamin Cohen MD MAS, , Stefan Holubar MD MS Arielle Kanters, Jessica Philpott, Taha Qazi, and Idan Goren discuss, “Multidisciplinary Approach to Pouchitis Management". Register today at bit.ly/IBD-Prime-Time….

☀️☀️ Arrived today from #WeTheFibrosisLab #STARConsortium ☀️☀️ Thank you Gut Journal for highlighting our work ☀️☀️ Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis gut.bmj.com/content/early/… Check it out 👇🏽A thread 🧵 (1/8) Miguel Regueiro Joseph Sleiman, MD

Check out what our 2023 IBDJournal & CC360 Editorial Fellows Bianca Islam, MD, PhD, MSc (she/her) and Raseen Tariq launched during their Editorial Fellowship this past year for #IBDJournal doi.org/10.1093/ibd/iz…

Thrilled to be part of the 2024 Editorial Fellows at IBDJournal & CC360! Ready to dive into meaningful work alongside this talented crew 📚

Bob Hollis Scott R. Steele Jeremy Lipman Benjamin Cohen MD MAS Jean-Paul Achkar Miguel Regueiro Steven D Wexner MD, PhD Florian Rieder Cleveland Clinic Alessandro Fichera

Geography impacts IBD outcomes 🌍 - lower SES and living in peripheral regions in Israel associated with nearly 2x rates of steroid use and surgery bit.ly/3wsc3z7

Insurance denials for IBD 💉💊 changes are common, even when guided by loss of response or drug levels 📊 bit.ly/4bSPNP6

For pts with UC slower to respond to initial mirikizumab induction, extended induction with 3 additional 300 mg IV doses every 4 weeks induced a clinical response in 53.7% of patients at W24 and clinical remission in 36.1% at W52. bit.ly/3VgwFVe

Study in Nature Communications by HabermanLab on the Urban-Rural diet-omic roots of IBD in China/Israel (our SOURCE Helmsley Charitable Trust consortium). Shows a gradient of IBD-like microbiome change correlating with time in city spent by villagers. doi.org/10.1038/s41467… Sheba Medical Center

MilestoneIBD selfie: Class of 2024. Congratulations to your graduation! 👋🏽👋🏿👋🏻 Christina Ha MD Carrie Bristor Mohammad Alomari, MD Idan Goren Manar Askar @KristiCBriggs Tarun Chhibba @akmd03 Dr. Jalpa Devi Miguel Regueiro Benjamin Cohen MD MAS Meena Bewtra Sara Horst MD, MPH, FACG Laura Raffals, MD Millie Long Joelle St-Pierre

Insights into how vedolizumab works 🔬 ⛔️ No difference in memory T cells cases vs controls 💥 But, reduction in dendritic cells from colonic biopsies exclusively in vedolizumab responsive patients Read more by Elisa Boden, MD here: bit.ly/3yWWxwb

Thank you, Florian Rieder #WeTheFibrosisLab🔬, for the heartfelt farewell. Working with this incredible team has been a privilege! Thanks to the clinical team Benjamin Cohen MD MAS Taha Qazi and to my long-term mentors, iris dotan Henit Yanai, for their friendship guidance and support!

IUS in IBD is great tech, but problem is standardization 🤔 This piece by Phillip Gu Dan Carter Dr Dermot McGovern Jason H. Moore, PhD et al. shows the promise of radiomics over traditional neural network AI models ⚠️ limitation is single center/operator doi.org/10.1093/crocol…

Congratulations to the new Advanced IBD Fellow grads from the Cleveland Clinic. It has truly been a pleasure learning and working from both of you this year. Idan Goren and Mohammad Alomari, MD. I know you’ll do great things!

Taha Qazi Mohammad Alomari, MD Thank you so much for your support Taha Qazi and Florian Rieder for this great opportunity. It's been an honor to be part of a phenomenal program, working with an amazing team and learning from the best Benjamin Cohen MD MAS Miguel Regueiro Taha Qazi Florian Rieder Jean-Paul Achkar Excited for what’s next!

Mohammad Alomari, MD Taha Qazi Idan Goren Benjamin Cohen MD MAS Florian Rieder Miguel Regueiro Manuel Braga Neto MD, PhD Congrats Mohammad Alomari, MD & Idan Goren !

Check out our lab’s latest paper on IBD-PSC. Lead author and main driver of the work is our former Sinai Health Advanced IBD Fellow Dr Haim Leibovitzh Haim Leibovitzh. He is now an IBD physician and scientist in Tel Aviv 🇮🇱 continuing his career as a staff physician there המרכז הרפואי ת״א - איכילוב.

New Piece on Advanced #Combined Therapy in #IBD pubmed.ncbi.nlm.nih.gov/39025253/ Shrinivas Bishu Waseem Ahmed Vipul Jairath MBChB DPhil Uma Mahadevan Edward Loftus

Discordant effects of #JAK ex-vivo on inflammatory responses in colonic compared to ileal mucosa Kaboub et al. Idan Goren iris dotan Jacob Ollech Henit Yanai academic.oup.com/ecco-jcc/advan…

Important data from PODCAST study🔊 Proportion of patients with inflammatory bowel disease with suboptimal disease control in daily clinical practice🔥 52% Crohn's disease & 44% ulcerative colitis👥 LOTS of room for improvement in monitoring & treatment onlinelibrary.wiley.com/doi/10.1002/ue…